EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

PUBLISHED Tuesday, April 28, 2026 · evolveimmune therapeutics

AI BRIEFING

⬤ EvolveImmune Therapeutics achieves preclinical milestone in collaboration with AbbVie
⬤ Successful nomination of development candidate for next-generation cancer biotherapeutic
⬤ Triggers $18 million milestone payment to EvolveImmune